UK health cost body backs Novartis asthma drug in fresh U-turn – Yahoo! News (blog)


Yahoo! News (blog)

UK health cost body backs Novartis asthma drug in fresh U-turn
Yahoo! News (blog)
LONDON (Reuters) – Britain's health cost-effectiveness watchdog NICE said it planned to recommend the use of Novartis's severe asthma drug Xolair after prevaricating for months over whether it should be paid for on the taxpayer-funded National Health
U-turn As Asthma Drug Gets Go-aheadThe Australian
NICE U-turn over asthma drug omalizumabGP online

all 3 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.